REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 23rd, 2014 • Oxigene Inc • Biological products, (no disgnostic substances)
Contract Type FiledMay 23rd, 2014 Company IndustryThis Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 23rd, 2014 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 23rd, 2014 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 22, 2014, between OXiGENE, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT OXIGENE, INC.Oxigene Inc • May 23rd, 2014 • Biological products, (no disgnostic substances)
Company FiledMay 23rd, 2014 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year and three month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from OXiGENE, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
May 22, 2014Oxigene Inc • May 23rd, 2014 • Biological products, (no disgnostic substances) • New York
Company FiledMay 23rd, 2014 Industry Jurisdiction
AMENDMENT NO. 8 TO STOCKHOLDER RIGHTS AGREEMENTStockholder Rights Agreement • May 23rd, 2014 • Oxigene Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 23rd, 2014 Company Industry JurisdictionThis Amendment No. 8 to Stockholder Rights Agreement (the “Amendment”), dated as of May , 2014, by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Rights Agent”), amends that certain Stockholder Rights Agreement, dated as of March 24, 2005, as amended as of October 1, 2008, October 14, 2009, March 10, 2010, January 18, 2011, November 28, 2011, April 11, 2013, and September 20, 2013, between the Company and the Rights Agent (as so amended, the “Agreement”).